Will CBO Score CREATE Momentum For Generic Bill's Passage?

Strong savings estimate – and brand pharma's need to have pay-fors for its own legislative priorities – could finally get bill allowing generic companies to sue brand sponsors for access to samples.

Washington DC Capitol dome detail with waving american flag

The US generics industry may finally have the leverage to pass a bill that would improve access to samples for testing after its savings were estimated at more than $3bn over 10 years.

The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act would allow generic companies to sue their brand counterparts...